KRAS gene mutation status and sensitivity to pemetrexed: A retrospective analysis.

被引：0
|
作者：
Kamdar, Manali K.
Parent, Teresa
Walker, Paul R.
机构：
[1] E Carolina Univ, DBA Vidant Med Ctr, Greenville, NC USA
[2] E Carolina Univ, Brody Sch Med, Leo Jenkins Canc Ctr, Greenville, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19154
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Bone Metastases and the EGFR and KRAS Mutation Status in Lung Adenocarcinoma - The Results of Three Year Retrospective Analysis
    Bittner, Nora
    Baliko, Zoltan
    Sarosi, Veronika
    Laszlo, Terezia
    Toth, Erika
    Kasler, Miklos
    Geczi, Lajos
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (04) : 1217 - 1221
  • [2] KRAS mutations predict sensitivity to pemetrexed-based chemotherapy
    Levy, Benjamin
    Drilon, Alexander
    Chachoua, Abraham
    Seetharamu, Nagashree
    Richardson, Stacy
    Lucido, David
    Legasto, Alan
    Grossbard, Michael
    Becker, Daniel
    LUNG CANCER MANAGEMENT, 2013, 2 (04) : 275 - 280
  • [3] KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer
    Nakayama, N.
    Nakayama, K.
    Yeasmin, S.
    Ishibashi, M.
    Katagiri, A.
    Iida, K.
    Fukumoto, M.
    Miyazaki, K.
    BRITISH JOURNAL OF CANCER, 2008, 99 (12) : 2020 - 2028
  • [4] KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer
    N Nakayama
    K Nakayama
    S Yeasmin
    M Ishibashi
    A Katagiri
    K Iida
    M Fukumoto
    K Miyazaki
    British Journal of Cancer, 2008, 99 : 2020 - 2028
  • [5] GENETIC ANALYSIS OF KRAS MUTATION STATUS IN METASTATIC COLORECTAL CANCER PATIENTS
    Zavodna, K.
    Konecny, M.
    Spanik, S.
    Galbavy, S.
    Vizvaryova, M.
    Weismanova, E.
    Kausitz, J.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4015 - 4016
  • [6] Genetic analysis of KRAS mutation status in metastatic colorectal cancer patients
    Zavodna, K.
    Konecny, M.
    Krivulcik, T.
    Spanik, S.
    Behulova, R.
    Vizvaryova, M.
    Weismanova, E.
    Galbavy, S.
    Kausitz, J.
    NEOPLASMA, 2009, 56 (03) : 275 - 278
  • [7] Targeted gene analysis reveals that active KRAS mutation is a prognostic mutation in mycosis fungoides
    Yanagi, Teruki
    Nishihara, Hiroshi
    Iwata, Hiroaki
    Shimizu, Hiroshi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB278 - AB278
  • [8] p53/KRAS Mutation Status Does Not Predict Sensitivity to Chemotherapy in NSCLC PDXs
    Mascaux, Celine
    Dhont, Ludovic
    Tomasini, Pascale
    Pham, Nhu-An
    Li, Ming
    Wang, Yuhui
    Stewart, Erin
    Waddell, Thomas K.
    Tsao, Ming S.
    Shepherd, Frances
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S215 - S215
  • [9] A NOVEL NONSENSE MUTATION IN KRAS GENE
    Palmirotta, Raffaele
    Savonarola, Annalisa
    Formica, Vincenzo
    Ludovici, Giorgia
    D'Alessandro, Roberta
    Leone, Barbara
    Ciancia, Marco
    Liberatore, Raffaela
    D'Angelo, Stella
    Roselli, Mario
    Guadagni, Fiorella
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3433 - 3433
  • [10] KRAS gene mutation in colorectal cancer
    Roa, Ivan
    Sanchez, Tamara
    Majlis, Alejandro
    Schalper, Kurt
    REVISTA MEDICA DE CHILE, 2013, 141 (09) : 1166 - 1172
12345